Evidence map›Paper›PMID 37772195›Full record

ArticleBulletin of the World Health Organization2023

Lessons from a global antimicrobial resistance surveillance network.

Etienne Ruppé, Network for Enhancing Tricycle ESBL Surveillance Efficiency (NETESE) group

Abstract read
In one paragraph

Article in Bulletin of the World Health Organization, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. The threat of multidrug-resistant microorganisms: active surveillance of key antimicrobial resistant pathogens in 2025 - a report from the INVIFAR network.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Etienne RuppéInfection, Antimicrobials, Modelling, Evolution (IAME), Institut National de la Santé et de la Recherche Médicale (INSERM), Université Paris Cité and Université Sorbonne Paris Nord, 16 rue Henri Huchard, Paris, F-75870, France.
Network for Enhancing Tricycle ESBL Surveillance Efficiency (NETESE) group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The World Health Organization developed the Tricycle surveillance programme to obtain a global picture of antimicrobial resistance, especially in countries with limited surveillance capacity. The programme was developed within a One Health perspective. Tricycle provides a framework for applying a standardized technical protocol to determining the prevalence of extended-spectrum β-lactamase (ESBL)-producing

Indexed as

Anti-Bacterial AgentsEscherichia coli InfectionsAnimalsbeta-LactamasesDrug Resistance, BacterialEscherichia coliHumansAnti-Bacterial Agentsbeta-Lactamases

Identifiers

PMID37772195
PMCPMC10523813

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.